-cell dedifferentiation in patients with T2D with adequate glucose control and nondiabetic chronic pancreatitis
They are not replacements for GLP-1 medications, they cant deliver the powerful, clinically proven effects of prescription therapies, and they are not regulated with the same rigor
Understanding these predispositions may support more targeted clinical decision-making
I'm like, "Ooh, I feel a little blood pressure change or something." Rhonda Patrick: And it makes sense
While semaglutide has gotten the most chatter, its one of several forms of GLP-1 medications currently on the market
To identify co-evolution between Gcg , and its encoded proglucagon-derived peptides, and Gcgr , Glp1r , and Glp2r , concatenated coding alignments (receptor plus Gcg sequences) were used